- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.11. | RedChip Companies, Inc.: BullFrog AI and Myriad Uranium Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 1.707 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / November 28, 2025 / RedChip Companies will air interviews with BullFrog AI, Inc. (Nasdaq:BFRG) and Myriad Uranium Corp. (OCTQB:MYRUF) on the RedChip Small Stocks, Big... ► Artikel lesen | |
| 18.11. | BullFrog AI Holdings, Inc.: BullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Complex Data into Actionable Insights | 4 | GlobeNewswire (USA) | ||
| 24.10. | BullFrog AI: Aktionäre stimmen für Kapitalerhöhung und Aktienzusammenlegung | 3 | Investing.com Deutsch | ||
| 24.10. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.10. | RedChip Companies, Inc.: BullFrog AI and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 384 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / October 24, 2025 / RedChip Companies will air interviews with BullFrog AI, Inc. (Nasdaq:BFRG) and Bimergen Energy Corp. (OCTQB:BESS) on the RedChip Small Stocks... ► Artikel lesen | |
| 10.10. | Bullfrog AI files to sell 5M shares of common stock for holders | 4 | Seeking Alpha | ||
| 10.10. | BullFrog AI Holdings, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| BULLFROG AI Aktie jetzt für 0€ handeln | |||||
| 09.10. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 23.09. | Bullfrog AI ändert Satzung und wählt Direktoren auf Hauptversammlung | 2 | Investing.com Deutsch | ||
| 23.09. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.09. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 08.09. | BullFrog AI Holdings, Inc.: BullFrog AI's bfPREP and bfLEAP Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration | 7 | GlobeNewswire (USA) | ||
| 27.08. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 13.08. | BullFrog AI Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 22.07. | BullFrog AI Holdings, Inc.: Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development | 4 | GlobeNewswire (USA) | ||
| 18.07. | RedChip Companies, Inc.: Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 435 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / July 18, 2025 / RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and BullFrog AI, Inc. (Nasdaq:BFRG) on the RedChip Small... ► Artikel lesen | |
| 20.06. | BullFrog AI Holdings, Inc.: BullFrog AI's Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar | 3 | GlobeNewswire (USA) | ||
| 11.04. | RedChip Companies, Inc.: Bullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 460 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / April 11, 2025 / RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited (Nasdaq:CNTB) and on... ► Artikel lesen | |
| 27.12.24 | BullFrog AI Holdings, Inc.: BullFrog AI Issues Letter to Stockholders | 299 | GlobeNewswire (Europe) | GAITHERSBURG, Md., Dec. 27, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial... ► Artikel lesen | |
| 17.12.24 | BullFrog AI Holdings, Inc.: BullFrog AI Announces Appointment of Chief Financial Officer | 295 | GlobeNewswire (Europe) | GAITHERSBURG, Md., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BB BIOTECH | 49,000 | +0,51 % | Jade Biosciences secures $45 million in private placement from BB Biotech | ||
| QIAGEN | 38,480 | +0,38 % | JEFFERIES stuft QIAGEN NV auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Qiagen mit einem Kursziel von 57 US-Dollar auf "Buy" belassen. Die Profitabilität dürfte 2026 zumindest stabil bleiben... ► Artikel lesen | |
| CUREVAC | 4,202 | -1,78 % | EILMELDUNG: Curevac-Aktie verliert deutlich - bricht jetzt das Vertrauen weg? | ||
| VALNEVA | 3,696 | -0,48 % | Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ | IXCHIQ- was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels remained high after twelve months in both dose groups... ► Artikel lesen | |
| AMGEN | 275,55 | -0,47 % | FDA Greenlights Amgen's UPLIZNA For Adults With Generalised Myasthenia Gravis | THOUSAND OAKS (dpa-AFX) - Amgen Inc. (AMGN), Friday, announced that the FDA has expanded UPLIZNA's label to include the treatment of generalized myasthenia gravis in adults who are positive... ► Artikel lesen | |
| NOVAVAX | 5,551 | -0,95 % | Why I Wouldn't Touch Novavax With a 10-Foot Pole | ||
| STRYKER | 299,40 | 0,00 % | Medizintechnik-Anbieter Stryker hebt erneut Dividende an | ||
| HEIDELBERG PHARMA | 2,700 | -0,37 % | EQS-News: Heidelberg Pharma AG: Heidelberg Pharma gibt Veränderungen im Vorstand bekannt - Dr. Dongzhou Jeffery Liu wird Mitglied des Vorstands und Vorstandsvorsitzender | EQS-News: Heidelberg Pharma AG
/ Schlagwort(e): Personalie
Heidelberg Pharma gibt Veränderungen im Vorstand bekannt - Dr. Dongzhou Jeffery Liu wird Mitglied des Vorstands und... ► Artikel lesen | |
| ILLUMINA | 114,32 | -0,40 % | MyOme, Inc: Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually | Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO... ► Artikel lesen | |
| CRISPR THERAPEUTICS | 47,600 | -0,42 % | CRISPR Therapeutics AG: CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310 Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering | -Data presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions 2025- -Phase 1 clinical data for CTX310® demonstrate robust, dose-dependent reductions in... ► Artikel lesen | |
| AAP IMPLANTATE | 1,380 | 0,00 % | aap Implantate: Kapitalerhöhung per Privatplatzierung | Die aap Implantate AG hat eine Barkapitalerhöhung um 788.150 Euro beschlossen, wodurch sich das Grundkapital auf 14,7 Millionen Euro erhöht. Die Maßnahme erfolgt durch die Ausgabe von 788.150 neuen... ► Artikel lesen | |
| OCUGEN | 1,210 | +2,63 % | Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit | ||
| SANGAMO THERAPEUTICS | 0,374 | -0,53 % | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy | RICHMOND, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has granted... ► Artikel lesen | |
| MAINZ BIOMED | 1,030 | 0,00 % | Mainz BioMed NV: DoctorBox Adds Mainz Biomed's ColoAlert(R) to Its Portfolio | BERKELEY, Calif. and MAINZ, Germany, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), molecular genetics diagnostic company specializing in the... ► Artikel lesen | |
| INFLARX | 0,864 | +0,94 % | InflaRx N.V.: InflaRx Announces International Nonproprietary Name of "Izicopan" for INF904 | JENA, Germany, Dec. 11, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced... ► Artikel lesen |
Das Unternehmen BULLFROG AI HOLDINGS INC kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell -4,55 % bei einem Aktienkurs von 1,050 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLFROG AI HOLDINGS INC finden Sie auf Wallstreet Online.